Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引:422
作者
Frueh, M. [1 ]
De Ruysscher, D. [2 ]
Popat, S. [3 ]
Crino, L. [4 ]
Peters, S. [5 ]
Felip, E. [6 ]
机构
[1] Kantonsspital St Gallen, Dept Med Oncol & Hematol, St Gallen, Switzerland
[2] Katholieke Univ Leuven, Univ Hosp Leuven, Louvain, Belgium
[3] Royal Marsden Hosp, London SW3 6JJ, England
[4] Hosp Santa Maria Misericordia, Dept Oncol, Perugia, Italy
[5] CHU Vaudois, Dept Oncol, Lausanne, Switzerland
[6] Vall dHebron Univ Hosp, Med Oncol Serv, Barcelona, Spain
关键词
PROPHYLACTIC CRANIAL IRRADIATION; PHASE-III TRIAL; QUALITY-OF-LIFE; RADIATION-THERAPY; THORACIC RADIOTHERAPY; 1ST-LINE TREATMENT; 7TH EDITION; RTOG; 0212; STAGE-I; CHEMOTHERAPY;
D O I
10.1093/annonc/mdt178
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:99 / 105
页数:7
相关论文
共 43 条
[1]  
Blackstock A William, 2005, Clin Lung Cancer, V6, P287, DOI 10.3816/CLC.2005.n.007
[2]   Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published randomized controlled trials [J].
Bozcuk, H ;
Artac, M ;
Ozdogan, M ;
Savas, B .
CANCER, 2005, 104 (12) :2650-2657
[3]   Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers [J].
Cuffe, Sinead ;
Moua, Teng ;
Summerfield, Ruth ;
Roberts, Heidi ;
Jett, James ;
Shepherd, Frances A. .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (04) :818-822
[4]   Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer [J].
De Ruysscher, D ;
Pijls-Johannesma, M ;
Bentzen, SM ;
Minken, A ;
Wanders, R ;
Lutgens, L ;
Hochstenbag, M ;
Boersma, L ;
Wouters, B ;
Lammering, G ;
Vansteenkiste, J ;
Lambin, P .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1057-1063
[5]   Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer [J].
Eckardt, John R. ;
von Pawel, Joachim ;
Pujol, Jean-Louis ;
Papai, Zsolt ;
Quoix, Elisabeth ;
Ardizzoni, Andrea ;
Poulin, Ruth ;
Preston, Alaknanda J. ;
Dane, Graham ;
Ross, Graham .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) :2086-2092
[6]   Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer [J].
Eckardt, JR ;
von Pawel, J ;
Papai, Z ;
Tomova, A ;
Tzekova, V ;
Crofts, TE ;
Brannon, S ;
Wissel, P ;
Ross, G .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2044-2051
[7]   Topotecan/Cisplatin Compared with Cisplatin/Etoposide as First-Line Treatment for Patients with Extensive Disease Small-Cell Lung Cancer Final Results of a Randomized Phase III Trial [J].
Fink, Thomas H. ;
Huber, Rudolf M. ;
Heigener, David F. ;
Eschbach, Corrina ;
Waller, Cornelius ;
Steinhauer, Ernst U. ;
Virchow, Johann C. ;
Eberhardt, Frank ;
Schweisfurth, Hans ;
Schroeder, Michael ;
Ittel, Thomas ;
Hummler, Simone ;
Banik, Norbert ;
Bogenrieder, Thomas ;
Acker, Thomas ;
Wolf, Martin .
JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) :1432-1439
[8]   Tumor Response and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Extensive Stage Small-Cell Lung Cancer Findings on the Basis of North Central Cancer Treatment Group Trials [J].
Foster, Nathan R. ;
Qi, Yingwei ;
Shi, Qian ;
Krook, James E. ;
Kugler, John W. ;
Jett, James R. ;
Molina, Julian R. ;
Schild, Steven E. ;
Adjei, Alex A. ;
Mandrekar, Sumithra J. .
CANCER, 2011, 117 (06) :1262-1271
[9]   Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer [J].
Fried, DB ;
Morris, DE ;
Poole, C ;
Rosenman, JG ;
Halle, JS ;
Detterbeck, FC ;
Hensing, TA ;
Socinski, MA .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (23) :4837-4845
[10]   Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database [J].
Govindan, Ramaswamy ;
Page, Nathan ;
Morgensztern, Daniel ;
Read, William ;
Tierney, Ryan ;
Vlahiotis, Anna ;
Spitznagel, Edward L. ;
Piccirillo, Jay .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) :4539-4544